Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02680301 · ClinicalTrials.gov registry record · Phase 4
Topical Steroid Formulation and Wet Wraps
A Phase 4 study of Dermatitis, Atopic, sponsored by Seton Healthcare Family.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02680301: Completed Phase 4 study of Dermatitis, Atopic, sponsored by Seton Healthcare Family.
NCT02680301 is a Phase 4 study of Dermatitis, Atopic that has completed, run by Seton Healthcare Family. The registered enrollment target is 40 participants, below the 396-participant average among 29 other Dermatitis, Atopic trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02680301, a Phase 4 study of Dermatitis, Atopic, has completed, sponsored by Seton Healthcare Family.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to 1. Compare efficacy of 0.1% triamcinolone containing wet wrap as an ointment or as a cream formulation in patients with moderate to severe atopic dermatitis 2. The relative patient/subject acceptance and adherence will also be compared between the two wet wrap types
Primary Outcome
Change in atopic dermatitis based on physician global assessment scale: 0=clear; 1=almost clear; 2=mild disease; 3=moderate disease; 4=severe disease; 5- very severe disease Lower scores represent a better outcome.
Conditions Studied
Interventions
- DRUG 0.1% triamcinolone CREAM
- DRUG 0.1% triamcinolone OINTMENT
Study Locations (1)
Texas
- Specially for Children Dermatology - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-06-01 |
| Phase | Phase 4 |
What the finished NCT02680301 record still lists
NCT02680301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 396-participant average among 29 other Dermatitis, Atopic trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Dermatitis, Atopic appearing as the primary indexed condition, and to 2 interventions - of which 0.1% triamcinolone CREAM is the first listed.
NCT02680301 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02680301 about?
NCT02680301 is a clinical study titled "Topical Steroid Formulation and Wet Wraps". The purpose of this study is to 1. Compare efficacy of 0.1% triamcinolone containing wet wrap as an ointment or as a cream formulation in patients with moderate to severe atopic dermatitis 2. The relative patient/subject acceptance and adherence will also be compared between the two wet wrap types
What is the current status of trial NCT02680301?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2016-03. Estimated completion is 2018-06-01.
What conditions does trial NCT02680301 study?
This clinical trial studies the following conditions: Dermatitis, Atopic.
What interventions are being tested in trial NCT02680301?
The interventions under investigation include: 0.1% triamcinolone CREAM (DRUG), 0.1% triamcinolone OINTMENT (DRUG).
Who is sponsoring clinical trial NCT02680301?
This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02680301 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatitis, Atopic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02680301's enrollment target sits among peer trials
40 27th of 29 higher than 3 of 29 other Dermatitis, Atopic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dermatitis, Atopic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis
ACTIVE NOT RECRUITING · Phase 4
-
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis
COMPLETED · Phase 4
-
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
RECRUITING · NA
-
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Effects of Treatments on Atopic Dermatitis
RECRUITING · Phase 2
-
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia